Neoplasms,%20Plasma%20Cell
Showing 9976 - 10000 of >10,000
Metastatic Malignant Tumor in the Brain, Primary Brain Tumor, Recurrent Brain Tumor Trial in Seattle (Computed Tomography,
Completed
- Metastatic Malignant Neoplasm in the Brain
- +2 more
- Computed Tomography
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 8, 2020
Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)
Recruiting
- Acute Leukemia
- mitoxantrone liposome
- ATG
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Feb 13, 2023
Langerhans Cell Histiocytosis Trial in Athens (Denosumab 70 MG/ML [Xgeva])
Completed
- Langerhans Cell Histiocytosis
- Denosumab 70 MG/ML [Xgeva]
-
Athens, Attiki, Greece251 Hellenic AirForce & VA General Hospital, Dpt of Endocrinolog
Oct 1, 2022
Acute Respiratory Distress Syndrome, Severe Pneumonia, Respiratory Failure Trial in Spain
Completed
- Acute Respiratory Distress Syndrome
- +2 more
-
Oviedo, Asturias, Spain
- +30 more
Jul 20, 2022
Acute Myocardial Infarction Trial in Taichung (Allogeneic umbilical cord mesenchymal stem cells)
Completed
- Acute Myocardial Infarction
- Allogeneic umbilical cord mesenchymal stem cells
-
Taichung, Non-US, TaiwanChina Medical University Hospital
Sep 5, 2022
Epstein-Barr Virus Infections, Post-Transplant Lymphoproliferative Disorder, Lymphoma Trial in Montreal (Group A, Group B)
Recruiting
- Epstein-Barr Virus Infections
- +2 more
- Group A
- Group B
-
Montreal, Quebec, CanadaHôpital Maisonneuve-Rosemont
Apr 5, 2022
Vascular Function, Healthy, Diabetes Trial (Soup)
Not yet recruiting
- Vascular Function
- +2 more
- Soup
- (no location specified)
Jul 28, 2023
Acute Myeloid Leukemia Trial in Wuhan (Fludarabine + Cyclophosphamide + TAA05 Cell Injection)
Recruiting
- Acute Myeloid Leukemia
- Fludarabine + Cyclophosphamide + TAA05 Cell Injection
-
Wuhan, Hubei, ChinaWuhan Union Hospital
Jun 29, 2022
Unresectable Stage III NSCLC Trial in Guangzhou (Anlotinib Hydrochloride)
Recruiting
- Unresectable Stage III Non-small Cell Lung Cancer
- Anlotinib Hydrochloride
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Sep 30, 2019
NSCLC (NSCLC) Trial in New York (Docetaxel, Gemcitabine, Lurbinectedin (PM01183))
Completed
- Non-Small Cell Lung Cancer (NSCLC)
- Docetaxel
- +2 more
-
New York, New York(unnamed)
Sep 4, 2019
Liver Transplantation, Erythrocyte Transfusion Trial in Rome (Red Blood Cell concentrates from organ donor)
Not yet recruiting
- Liver Transplantation
- Erythrocyte Transfusion
- Red Blood Cell concentrates from organ donor
-
Rome, ItalyFondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023
Cornea Ulcer Trial in Cairo (Autologous platelet-rich plasma (PRP) eye drops)
Completed
- Cornea Ulcer
- Autologous platelet-rich plasma (PRP) eye drops
-
Cairo, EgyptAl-Azhar University
Aug 23, 2022
Chronic Kidney Disease Trial in Rochester (Group 2: Dasatinib, Group 2: Quercetin)
Enrolling by invitation
- Chronic Kidney Disease
- Group 2: Dasatinib
- Group 2: Quercetin
-
Rochester, MinnesotaMayo Clinic in Rochester
May 14, 2022
T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)
Terminated
- T-cell Non-Hodgkin Lymphoma
- Cyclophosphamide
- +12 more
-
Boston, Massachusetts
- +1 more
Jan 26, 2023
Glycaemia and Cardiac Function in Patients With COVID-19
Recruiting
- Diabetes Mellitus
- +3 more
- Glycaemic levels
-
Hellerup, Please Select, Denmark
- +1 more
Oct 4, 2021
A New Protocol for Continuous Vancomycin Infusion Dosing.
Completed
- Sepsis
- Vancomycin Treatment
- Plasma vancoymcin measurements
-
Stockholm, SwedenKarolinska University Hospital Solna
Nov 22, 2021
Neat OGTT, OGTT With Added Sucralose, OGTT With Added Lactisole Trial in New Brunswick (TAS1R2/3 agonist or antagoinst admixture
Completed
- Neat OGTT
- +2 more
- TAS1R2/3 agonist or antagoinst admixture to oral glucose tolerance test
-
New Brunswick, New JerseyRutgers, Department of Nutritional Sciences
Jun 2, 2023
Glioblastoma, IDH-wildtype, Metformin, Malignancies Trial in Milan (Metformin)
Not yet recruiting
- Glioblastoma, IDH-wildtype
- +2 more
-
Milan, ItalyFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Mil
Jun 26, 2023
Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium
Not yet recruiting
- Delirium, Postoperative
- +2 more
- (no location specified)
Sep 18, 2023
Anaplastic Large Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype, Recurrent Anaplastic Large Cell Lymphoma
Recruiting
- Anaplastic Large Cell Lymphoma
- +19 more
- Pembrolizumab
- Pralatrexate
-
Duarte, California
- +2 more
Aug 15, 2022
Relapsed/Refractory Mantle Cell Lymphoma Trial in Worldwide (Fludarabine, Cyclophosphamide, Brexucabtagene autoleucel)
Recruiting
- Relapsed/Refractory Mantle Cell Lymphoma
- Fludarabine
- +2 more
-
Gilbert, Arizona
- +40 more
Jan 6, 2023
Anatomic Stage IV Breast Cancer AJCC v8, HER2 Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States
Withdrawn
- Anatomic Stage IV Breast Cancer AJCC v8
- +3 more
- Abemaciclib
- Trastuzumab Emtansine
-
Yuma, Arizona
- +5 more
May 25, 2022
Procalcitonin, C-Reactive Protein, and WBC Count in Prediction
Completed
- Anastomotic Leak
- CRP, PCT, and WBCs trajectories
-
Mansourah, Dakahlia, EgyptMansoura university hospital
Dec 1, 2021